Khiron Life Sciences (TSXV:KHRN, OTCQB:KHRNF) President Chris Naprawa recently joined the Dales Report to discuss his company’s progress in the Latin American cannabis market. Naprawa believes the legalization of cannabis is a global movement and has positioned the company to take advantage of international developments.

According to Naprawa, the Latin American market is home to over 620 million people, providing Khiron with a massive opportunity as each jurisdiction legalizes cannabis across the continent. Rather than focus on cultivation and crop yields, Naprawa feels that branding and strong business relationships are critical to success in the cannabis business. “It’s not imperative to own the entire value chain. Brands and customer relationships, that’s where the real value is and that’s where we are focused,” said Naprawa.

Khiron is also working to establish positive relationships with doctors and physicians in order to educate the medical community regarding the potential benefits of cannabis. On the recreational side of the market, Khiron has recently launched the Kuida brand across the United States, with 48 stores initially carrying the company’s wellness products including body lotions, creams, mists and other topical products. The company intends to launch the product line in California in the next month as well. Naprawa is confident that Khiron’s expansion strategy and leadership team have been designed for success, partially due to the presence of major contributors like Director Vincente Fox, the former president of Mexico.

To watch the full interview, click here.

Click here to connect with Khiron Life Sciences (TSXV:KHRN, OTCQB:KHRNF) and to request an investor presentation. 

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less

 Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.

For more information regarding the Company or the offering, please contact, or

Keep reading... Show less